Just a moment, the page is loading...

GSK-29060/01/001




A Phase II, Placebo-Controlled, Double-Blind Study of Paroxetine in Depressed Outpatients
paroxetine
29060/01/001
Depressive Disorder
Phase 2
An analysis-ready dataset is not available for this study. An annotated case report form and a reporting and analysis plan are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.
May 2014